List of Studies ( Metabolite:Asp-Leu-Ser)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003565 | AN005858 | Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003179 | AN005222 | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002078 | AN003387 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003388 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003389 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003390 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002024 | AN003294 | Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003277 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003278 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003279 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Blood | Human | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Cultured cells | Human | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001384 | AN002309 | Plasmodium falciparum increased time in circulation underlies persistent asymptomatic infection in the dry season | Blood | Human | Malaria | Pennsylvania State University | LC-MS |
| ST001279 | AN002120 | K13 mutations driving artemisinin resistance rewrite Plasmodium falciparum’s programmed intra-erythrocytic development and transform mitochondrial physiology | Parasite | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001232 | AN002050 | Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001149 | AN001896 | Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001008 | AN001650 | Multi-Platform Physiologic and Metabolic Phenotyping Reveals Microbial Toxicity (part II) | Cecum | Mouse | Pennsylvania State University | LC-MS |
